Search results
Principal Scientist - Biopharmaceutics, Merck - Cited by 946 - Oral Drug Delivery - Intestinal Biology - Peptide Drugs - IVIVC.
Research Scientist in Biopharmaceutics at Merck/MSD. I’m an expert in oral drug delivery, permeation enhancers, and intestinal absorption of drugs, nutrients, and cells. PhD at UCD...
May 8, 2017 · J. P. Gleeson. First published: 08 May 2017. https://doi.org/10.1111/nbu.12260. Citations: 16. Read the full text. PDF. Tools. Share. Abstract. The majority of dietary nutrient absorption occurs in the small intestine, with the intestinal epithelium acting as a barrier to the contents of the intestinal lumen.
Contributors: John P. Gleeson; Namit Chaudhary; Katherine C. Fein; Rose Doerfler; Patricia Hredzak-Showalter; Kathryn A. Whitehead
John P Gleeson's 40 research works with 2,163 citations and 11,126 reads, including: An Innovative miR‐Activated Scaffold for the Delivery of a miR‐221 Inhibitor to Enhance Cartilage Defect...
Jan 29, 2009 · Abstract. The objective of this study was to develop a biomimetic, highly porous collagen-hydroxyapatite (HA) composite scaffold for bone tissue engineering (TE), combining the biological performance and the high porosity of a collagen scaffold with the high mechanical stiffness of a HA scaffold.
John Patrick Gleeson. Post-Doctorate. Senior Researcher. Merck & Co., Inc. Kenilworth, United States. John Gleeson. Overview. Bio. Network 3.
